|1.||Rouleau, J L: 1 article (05/2003)|
|2.||Lapointe, N: 1 article (05/2003)|
|3.||Canadian Prospective RandOmized FlosequInan Longevity Evaluation Investigators: 1 article (05/2003)|
|4.||Hansen, M S: 1 article (05/2003)|
|5.||Swedberg, K: 1 article (05/2003)|
|6.||Pitt, B: 1 article (05/2003)|
|7.||Dhalla, N S: 1 article (05/2003)|
|8.||Stanton, E: 1 article (05/2003)|
|9.||Packer, M: 1 article (05/2003)|
|10.||Dhalla, K S: 1 article (05/2003)|
05/01/2003 - "The purpose of this study was to assess whether adrenolutin, the inert product of the highly reactive molecules aminochromes, is increased in severe chronic heart failure and whether it is associated with a poor prognosis. "
05/01/2003 - "Plasma adrenolutin is increased in patients with heart failure and correlates with a poor prognosis independent of other important predictors of survival. "
05/01/2003 - "Adrenolutin was measured at baseline and at 1 and 3 months in 263 patients with chronic New York Heart Association class III or IV heart failure and a left ventricular ejection fraction of 22% +/- 7%. "
05/01/2003 - "Prognostic importance of the oxidized product of catecholamines, adrenolutin, in patients with severe heart failure."
07/01/1970 - "V. Excessive hemolysis associated with the formation of rheomelanins during incubation of adrenochrome and adrenolutin in the bloods of chronic schizophrenic patients."
07/01/1970 - "IV. Hemolysis associated with the transformation of l-epinephrine, adrenochrome and adrenolutin into rheomelanins in human whole blood."